Cornbread Hemp warns that a federal funding bill could reclassify its hemp products as Schedule I drugs, effectively banning them by 2026 unless Congress revises the language.

The measure targets products with any detectible amount of THC, including non-intoxicating, full-spectrum CBD that is currently legal.